CD8A and X-linked lymphoproliferative disease: These data provide compelling evidence that the unique susceptibility to EBV infection in XLP patients is due to the inability of SAP− CD8+ T cells to respond to Ag-presenting B cells due to inhibitory signalling mediated by SLAM family receptors, rather than an inability to recognise and respond to EBV Ags.